ClinicalTrials.Veeva

Menu

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

B

Brasilia University Hospital

Status and phase

Completed
Phase 4

Conditions

Underdosing of Unspecified General Anesthetics

Treatments

Drug: Remifentanil

Study type

Interventional

Funder types

Other

Identifiers

NCT02454868
UBrasilia

Details and patient eligibility

About

Introduction: remifentanil's optimal dose for children intubation without neuromuscular blockade is unknown. Method: phase IV adaptative trial using Dixon's up-and-down method for modeling remifentanil's dose-response curve for adequate intubation conditions as defined by previous studies.

Full description

Introduction: remifentanil's optimal dose for children intubation without neuromuscular blockade is unknown.

Method: phase IV adaptative trial using Dixon's up-and-down method for modeling remifentanil's dose-response curve for adequate intubation conditions as defined by previous studies. Remifentanil doses starting from 2mg/kg will be infused before intubation. When a success occurs next patient's dose will be decreased by 0.25mg/kg/h. When a success does not occur the next patient's dose will be increased by 0.25mg/kg/h. Intubation will be considered adequate if patient does not cough, does not move, if vocal cords are open, if larigocsocpic Cormack grade I or II.

Enrollment

30 patients

Sex

All

Ages

2 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA I or II
  • Scheduled for surgery under general anesthesia.

Exclusion criteria

  • Predicted difficult airway
  • Severe neurologic or cardiologic conditions
  • Recent upper airway infectious diseases

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Study arm
Experimental group
Description:
There is a single study arm. Remifentanil will be infused before intubation. The first patient will receive remifentanil 2mg/kg. If a success occurs the next patient's dose will be decreased by 0.25mg/kg and else it will be increased by 0.25mg/kg. This rule will apply recursively as Dixon's Up-And-Down Method.
Treatment:
Drug: Remifentanil

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems